Circulating tumor cells and coagulation − minireview

Publication date: Available online 6 April 2017
Source:Critical Reviews in Oncology/Hematology
Author(s): Branislav Bystricky, James M. Reuben, Michal Mego
Venous thromboembolic events in cancer patients signify poor prognosis. Prophylactic treatment of ambulatory patients with anticoagulants is currently not recommended. Circulating tumor cells, either directly or indirectly, are associated with prothrombotic state. In this review, we discuss various interactions of circulating tumor cells with the coagulation pathway in cancer patient.



http://ift.tt/2ngUU7a